• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PCNA 在肿瘤干性和侵袭中的功能。

The Functions of PCNA in Tumor Stemness and Invasion.

机构信息

Graduate Institute of Biomedical Sciences, College of Medicine, China Medical University, Taichung 40402, Taiwan.

Center for Molecular Medicine, China Medical University Hospital, Taichung 40447, Taiwan.

出版信息

Int J Mol Sci. 2022 May 19;23(10):5679. doi: 10.3390/ijms23105679.

DOI:10.3390/ijms23105679
PMID:35628489
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9143764/
Abstract

Invasion is the most prominent lethal feature of malignant cancer. However, how cell proliferation, another important feature of tumor development, is integrated with tumor invasion and the subsequent cell dissemination from primary tumors is not well understood. Proliferating cell nuclear antigen (PCNA) is essential for DNA replication in cancer cells. Loss of phosphorylation at tyrosine 211 (Y211) in PCNA (pY211-PCNA) mitigates PCNA function in proliferation, triggers replication fork arrest/collapse, which in turn sets off an anti-tumor inflammatory response, and suppresses distant metastasis. Here, we show that pY211-PCNA is important in stromal activation in tumor tissues. Loss of the phosphorylation resulted in reduced expression of mesenchymal proteins as well as tumor progenitor markers, and of the ability of invasion. Spontaneous mammary tumors that developed in mice lacking Y211 phosphorylation contained fewer tumor-initiating cells compared to tumors in wild-type mice. Our study demonstrates a novel function of PCNA as an essential factor for maintaining cancer stemness through Y211 phosphorylation.

摘要

侵袭是恶性肿瘤最显著的致命特征。然而,细胞增殖(肿瘤发展的另一个重要特征)如何与肿瘤侵袭以及随后的肿瘤细胞从原发性肿瘤中扩散相整合,目前还不是很清楚。增殖细胞核抗原(PCNA)是癌细胞中 DNA 复制所必需的。PCNA 中酪氨酸 211 位点(Y211)的磷酸化缺失(pY211-PCNA)减轻了 PCNA 在增殖中的功能,引发复制叉停滞/崩溃,从而引发抗肿瘤炎症反应,并抑制远处转移。在这里,我们表明 pY211-PCNA 在肿瘤组织中的基质激活中很重要。磷酸化缺失导致间充质蛋白以及肿瘤祖细胞标记物的表达减少,侵袭能力也降低。与野生型小鼠相比,缺乏 Y211 磷酸化的小鼠自发形成的乳腺肿瘤中,肿瘤起始细胞的数量减少。我们的研究表明,PCNA 通过 Y211 磷酸化作为维持癌症干细胞的必需因素发挥了新的功能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba9b/9143764/c6f9be12b076/ijms-23-05679-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba9b/9143764/062947d544bc/ijms-23-05679-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba9b/9143764/f2da605c2616/ijms-23-05679-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba9b/9143764/62a0d280f8de/ijms-23-05679-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba9b/9143764/c95f651cc8fe/ijms-23-05679-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba9b/9143764/d4cec6394395/ijms-23-05679-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba9b/9143764/c6f9be12b076/ijms-23-05679-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba9b/9143764/062947d544bc/ijms-23-05679-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba9b/9143764/f2da605c2616/ijms-23-05679-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba9b/9143764/62a0d280f8de/ijms-23-05679-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba9b/9143764/c95f651cc8fe/ijms-23-05679-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba9b/9143764/d4cec6394395/ijms-23-05679-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ba9b/9143764/c6f9be12b076/ijms-23-05679-g006.jpg

相似文献

1
The Functions of PCNA in Tumor Stemness and Invasion.PCNA 在肿瘤干性和侵袭中的功能。
Int J Mol Sci. 2022 May 19;23(10):5679. doi: 10.3390/ijms23105679.
2
The Ron receptor tyrosine kinase activates c-Abl to promote cell proliferation through tyrosine phosphorylation of PCNA in breast cancer.Ron 受体酪氨酸激酶通过酪氨酸磷酸化 PCNA 激活 c-Abl,从而促进乳腺癌细胞增殖。
Oncogene. 2014 Mar 13;33(11):1429-37. doi: 10.1038/onc.2013.84. Epub 2013 Apr 1.
3
Evading immune surveillance via tyrosine phosphorylation of nuclear PCNA.通过核 PCNA 的酪氨酸磷酸化逃避免疫监视。
Cell Rep. 2021 Aug 24;36(8):109537. doi: 10.1016/j.celrep.2021.109537.
4
Targeting tyrosine phosphorylation of PCNA inhibits prostate cancer growth.靶向 PCNA 的酪氨酸磷酸化抑制前列腺癌生长。
Mol Cancer Ther. 2011 Jan;10(1):29-36. doi: 10.1158/1535-7163.MCT-10-0778.
5
Phosphorylation of PCNA by EGFR inhibits mismatch repair and promotes misincorporation during DNA synthesis.表皮生长因子受体介导的增殖细胞核抗原磷酸化会抑制错配修复,并在DNA合成过程中促进错误掺入。
Proc Natl Acad Sci U S A. 2015 May 5;112(18):5667-72. doi: 10.1073/pnas.1417711112. Epub 2015 Mar 30.
6
Interaction of proliferation cell nuclear antigen (PCNA) with c-Abl in cell proliferation and response to DNA damages in breast cancer.增殖细胞核抗原(PCNA)与 c-Abl 在乳腺癌细胞增殖和对 DNA 损伤反应中的相互作用。
PLoS One. 2012;7(1):e29416. doi: 10.1371/journal.pone.0029416. Epub 2012 Jan 4.
7
Targeting the EGFR/PCNA signaling suppresses tumor growth of triple-negative breast cancer cells with cell-penetrating PCNA peptides.靶向 EGFR/PCNA 信号通路抑制穿膜 PCNA 肽抑制三阴性乳腺癌细胞的肿瘤生长。
PLoS One. 2013 Apr 8;8(4):e61362. doi: 10.1371/journal.pone.0061362. Print 2013.
8
Phosphorylation at tyrosine 114 of Proliferating Cell Nuclear Antigen (PCNA) is required for adipogenesis in response to high fat diet.增殖细胞核抗原(PCNA)酪氨酸 114 位的磷酸化对于高脂饮食诱导的脂肪生成是必需的。
Biochem Biophys Res Commun. 2013 Jan 4;430(1):43-8. doi: 10.1016/j.bbrc.2012.11.047. Epub 2012 Nov 28.
9
Nuclear insulin-like growth factor 1 receptor phosphorylates proliferating cell nuclear antigen and rescues stalled replication forks after DNA damage.细胞核胰岛素样生长因子1受体使增殖细胞核抗原磷酸化,并在DNA损伤后挽救停滞的复制叉。
J Biol Chem. 2017 Nov 3;292(44):18227-18239. doi: 10.1074/jbc.M117.781492. Epub 2017 Sep 18.
10
Loss of tyrosine 211 phosphorylation of proliferating cell nuclear antigen (PCNA) enhances postnatal mammary gland development.增殖细胞核抗原(PCNA)酪氨酸211位点磷酸化的缺失促进产后乳腺发育。
Biomedicine (Taipei). 2024 Sep 1;14(3):40-48. doi: 10.37796/2211-8039.1462. eCollection 2024.

引用本文的文献

1
Sonodynamic Therapy-Based DNA Nanocarriers with Hypoxia-Inducible Factor-1α Silencing Activation for Precision Lung Cancer Therapy.基于声动力疗法的DNA纳米载体,具有缺氧诱导因子-1α沉默激活功能,用于精准肺癌治疗。
Biomater Res. 2025 Aug 21;29:0230. doi: 10.34133/bmr.0230. eCollection 2025.
2
Identification of genes associated with hepatitis B virus infection and breast cancer tumorigenesis and progression.鉴定与乙型肝炎病毒感染以及乳腺癌发生和进展相关的基因。
Biochem Biophys Rep. 2025 Jul 14;43:102156. doi: 10.1016/j.bbrep.2025.102156. eCollection 2025 Sep.
3
N-ethyl-N-nitrosourea (ENU) alters cytokine expression in the bone marrow modifying the marrow microenvironment to develop leukemia.

本文引用的文献

1
Evading immune surveillance via tyrosine phosphorylation of nuclear PCNA.通过核 PCNA 的酪氨酸磷酸化逃避免疫监视。
Cell Rep. 2021 Aug 24;36(8):109537. doi: 10.1016/j.celrep.2021.109537.
2
Is the C-C Motif Ligand 2-C-C Chemokine Receptor 2 Axis a Promising Target for Cancer Therapy and Diagnosis?C-C 基序趋化因子配体 2-C-C 趋化因子受体 2 轴是癌症治疗和诊断的有前途的靶点吗?
Int J Mol Sci. 2020 Dec 7;21(23):9328. doi: 10.3390/ijms21239328.
3
A framework for advancing our understanding of cancer-associated fibroblasts.推进我们对癌症相关成纤维细胞理解的框架。
N-乙基-N-亚硝基脲(ENU)改变骨髓中的细胞因子表达,从而改变骨髓微环境以引发白血病。
Med Oncol. 2025 Jul 12;42(8):324. doi: 10.1007/s12032-025-02882-3.
4
Tailoring a novel colorectal cancer stem cell-targeted therapy by inhibiting the SMYD3/c-MYC axis.通过抑制SMYD3/c-MYC轴定制一种新型的结直肠癌干细胞靶向治疗方法。
Signal Transduct Target Ther. 2025 Jun 30;10(1):206. doi: 10.1038/s41392-025-02290-z.
5
Targeting PCNA/PARP1 axis inhibits the malignant progression of hepatocellular carcinoma.靶向PCNA/PARP1轴可抑制肝细胞癌的恶性进展。
Front Pharmacol. 2025 Apr 17;16:1571786. doi: 10.3389/fphar.2025.1571786. eCollection 2025.
6
Sodium Butyrate: A Multifaceted Modulator in Colorectal Cancer Therapy.丁酸钠:结直肠癌治疗中的多面调节剂
Medicina (Kaunas). 2025 Jan 15;61(1):136. doi: 10.3390/medicina61010136.
7
Loss of tyrosine 211 phosphorylation of proliferating cell nuclear antigen (PCNA) enhances postnatal mammary gland development.增殖细胞核抗原(PCNA)酪氨酸211位点磷酸化的缺失促进产后乳腺发育。
Biomedicine (Taipei). 2024 Sep 1;14(3):40-48. doi: 10.37796/2211-8039.1462. eCollection 2024.
8
The possible anti-tumor actions and mechanisms of active metabolites from Cortex Fraxini.秦皮活性代谢产物可能的抗肿瘤作用及机制
Front Pharmacol. 2024 Sep 13;15:1404172. doi: 10.3389/fphar.2024.1404172. eCollection 2024.
9
USP14 inhibition promotes DNA damage repair and represses ovarian granulosa cell senescence in premature ovarian insufficiency.USP14 抑制促进 DNA 损伤修复并抑制早发性卵巢功能不全中的卵巢颗粒细胞衰老。
J Transl Med. 2024 Sep 11;22(1):834. doi: 10.1186/s12967-024-05636-3.
10
Brusatol enhances MEF2A expression to inhibit RCC progression through the Wnt signalling pathway in renal cell carcinoma.桦木酸通过 Wnt 信号通路增强 MEF2A 表达抑制肾细胞癌进展。
J Cell Mol Med. 2023 Dec;27(23):3897-3910. doi: 10.1111/jcmm.17972. Epub 2023 Oct 20.
Nat Rev Cancer. 2020 Mar;20(3):174-186. doi: 10.1038/s41568-019-0238-1. Epub 2020 Jan 24.
4
Therapeutic targeting of the crosstalk between cancer-associated fibroblasts and cancer stem cells.针对癌症相关成纤维细胞与癌症干细胞之间相互作用的治疗靶点
Am J Cancer Res. 2019 Sep 1;9(9):1889-1904. eCollection 2019.
5
Phosphorylation of proliferating cell nuclear antigen promotes cancer progression by activating the ATM/Akt/GSK3β/Snail signaling pathway.增殖细胞核抗原的磷酸化通过激活 ATM/Akt/GSK3β/Snail 信号通路促进癌症进展。
J Biol Chem. 2019 Apr 26;294(17):7037-7045. doi: 10.1074/jbc.RA119.007897. Epub 2019 Mar 11.
6
A distinct role for Lgr5 stem cells in primary and metastatic colon cancer.Lgr5 干细胞在原发性和转移性结肠癌中的独特作用。
Nature. 2017 Mar 29;543(7647):676-680. doi: 10.1038/nature21713.
7
Forging Ahead through Darkness: PCNA, Still the Principal Conductor at the Replication Fork.在黑暗中奋勇前行:增殖细胞核抗原,依然是复制叉处的主要指挥者。
Mol Cell. 2017 Feb 2;65(3):380-392. doi: 10.1016/j.molcel.2016.12.020.
8
Hallmarks of cancer stem cell metabolism.癌症干细胞代谢的特征。
Br J Cancer. 2016 Jun 14;114(12):1305-12. doi: 10.1038/bjc.2016.152. Epub 2016 May 24.
9
MYC/PGC-1α Balance Determines the Metabolic Phenotype and Plasticity of Pancreatic Cancer Stem Cells.MYC/PGC-1α 平衡决定了胰腺癌干细胞的代谢表型和可塑性。
Cell Metab. 2015 Oct 6;22(4):590-605. doi: 10.1016/j.cmet.2015.08.015. Epub 2015 Sep 10.
10
Comprehensive molecular characterization of gastric adenocarcinoma.胃腺癌的全面分子特征分析。
Nature. 2014 Sep 11;513(7517):202-9. doi: 10.1038/nature13480. Epub 2014 Jul 23.